by Ned Mumtaz | Jul 17, 2026 | en
tradurre in italiano The Italian Sunshine Act: What Medical Device Companies Need to Know Before Their First Disclosure Table of content What the Confindustria Dispositivi Medici Framework Did—and What It Did Not How the Italian Sunshine Act Changes the Position Where...
by Umer Tanweer | Jul 9, 2026 | en
tradurre in italiano Codice Fiscale, GDPR, and the Italian Sunshine Act: What Global Companies Need to Know About HCP Data in Italy Table of content The Codice Fiscale Requirement The GDPR Complication What the Telematic Register Will Require Building the Right...
by Ned Mumtaz | Jun 11, 2026 | en
tradurre in italiano Why the Italian Sunshine Act Is More Operationally Complex Than US Open Payments Table of content Italy’s Life Sciences Market Demands Attention Broader Covered Entities, Including Sectors the US Does Not Touch A Broader Pool of Covered...
by May Khan | Jun 4, 2026 | Blog
Translate in English Trasferimenti di valore: il concetto che le aziende italiane del settore Life Sciences non possono permettersi di sbagliare Table of content La vera domanda non è solo come rendicontare, ma anche cosa rendicontare Perché le aziende sottovalutano...
by May Khan | Jun 4, 2026 | en
tradurre in italiano Transfers of Value: The One Concept Italian Life Sciences Companies Cannot Afford to Get Wrong Table of content The Real Question Is Not Only How to Report — It Is Also What to Report Why Companies Underestimate This Step What Good TOV Preparation...
